Terms and conditions of use
Please review these terms carefully before using our website or services. By accessing or using our site, you agree to these conditions.
August 29, 2025
Acceptance of terms
By using this website, you acknowledge and accept these terms and any additional policies referenced. Continued use implies agreement, so please review them regularly for updates.
Definitions
To ensure clarity, here are key terms used throughout these conditions.
- ‘Website’ refers to calyronivax.com and all related pages and content.
- ‘Services’ means all consultations, reviews, and guidance provided by calyronivax.
- ‘User’ means anyone who visits, accesses, or uses our website or services.
- ‘Content’ includes all text, graphics, and materials presented on the site.
Use of our services
Our services are intended for informational and guidance purposes only. We do not offer or endorse financial products or investments.
Eligibility
You must be at least 18 years old and legally able to enter agreements to use our services. By using this site, you confirm your eligibility.
18+ only for all consultations.
User responsibilities
Users must act honestly and respectfully when using this website.
- Provide accurate information during any enquiry or consultation.
- Respect intellectual property and do not misuse site content.
- Comply with all applicable laws and regulations.
- Do not attempt unauthorised access or data misuse.
Prohibited uses
Do not use our site for any illegal or harmful activities.
- Distributing false or misleading information.
- Attempting to access or alter confidential data.
- Using automated tools to disrupt site operation.
- Posting unlawful, offensive, or defamatory material.
- Violating any local or international law.
Intellectual property rights
All content, branding, and materials on this website are owned or licensed by calyronivax. You may not copy, reproduce, or distribute any materials without written permission.
User content
If you submit content, you grant us a right to use it for service delivery, subject to our privacy policy.
Your user content rights:
You retain ownership of your content but are responsible for its legality and accuracy.
Privacy and data protection
We are committed to protecting your information as described in our privacy policy. Please review it for full details on how your data is handled. Read privacy policy
Website disclaimer and notices
Please read our disclaimer for important information about the use of website content.
Key warnings:
No content on this site constitutes financial, legal, or investment advice. Results may vary.
Limitation of liability
We are not liable for any loss or damage arising from your use of the site or reliance on its content.
Indemnification
By using this website, you agree to indemnify and hold us harmless from any claims or damages related to your use.
Resolving disputes
Disputes should be raised with us directly for prompt resolution.
Arbitration
If a dispute cannot be resolved, it may be referred to confidential arbitration in accordance with Australian law.
Arbitration does not waive your statutory rights.
Online dispute resolution
You may also use online dispute resolution services for certain issues, where available.
Learn about dispute resolution: Learn about dispute resolution
Applicable law and jurisdiction
These terms are governed by Australian law, and all disputes fall under its jurisdiction.
Termination
We reserve the right to suspend or terminate access for any user violating these terms or engaging in prohibited conduct.
Changes
We may update these terms at any time. Users should review them regularly for updates.
Severability
If any section is found invalid, the remainder remains in effect.
Entire agreement
These terms, together with referenced policies, constitute the full agreement between you and calyronivax.
Contact us
For questions about these terms, please use the contact details below.
Email address: content@calyronivax.com
Contact number: +61 7 0549 8065
Office address: 265 King Street, Newcastle, NSW 2300 Australia
Effective date: August 29, 2025
Version: 1.1